Molecular genetics of B-precursor acute lymphoblastic leukemia
Open accessThe DOI matches its Crossref record; 126 of the 127 references it cites were found in a registry or an index.
Abstract
B-precursor acute lymphoblastic leukemia (B-ALL) is the most common childhood tumor and the leading cause of cancer-related death in children and young adults. The majority of B-ALL cases are aneuploid or harbor recurring structural chromosomal rearrangements that are important initiating events in leukemogenesis but are insufficient to explain the biology and heterogeneity of disease. Recent studies have used microarrays and sequencing to comprehensively identify all somatic genetic alterations in acute lymphoblastic leukemia (ALL). These studies have identified cryptic or submicroscopic genetic alterations that define new ALL subtypes, cooperate with known chromosomal rearrangements, and influence prognosis. This article reviews these advances, discusses results from ongoing second-generation sequencing studies of ALL, and highlights challenges and opportunities for future genetic profiling approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“BCP-ALL, which is characterized by a block in lymphoid differentiation leading to the accumulation of immature progenitor cells.37”
From PELI2 regulates early B-cell progenitor differentiation and related leukemia via the IL-7R expression (2023) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243 · cited 1×
“org Volume 122 Number 10 October 2012 3409 such as imatinib mesylate (Gleevec) have transformed the treatment and outcome of patients with BCR-ABL1–positive leukemia (40, 41).”
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713 · cited 1×
“org Volume 122 Number 10 October 2012 3409 such as imatinib mesylate (Gleevec) have transformed the treatment and outcome of patients with BCR-ABL1–positive leukemia (40, 41).”
Yeoh, E.-J., Ross, M. E., Shurtleff, S. A., Williams, W. K., Patel, D., Mahfouz, R., Behm, F. G., Raimondi, S. C., Relling, M. V., Patel, A., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00032-6 · Cited by 1,917 · cited 1×
“These approaches, coupled with candidate gene sequencing and integrated gene expression profiling (92), have identified a number of critical new targets of mutation in B-ALL that often involve genes that regulate lymphoid development, cell cycle, tumor suppression, and a variety of other key…”
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan-Smith, E., Dalton, J. D., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,801 · cited 6×
“The nature and frequency of these CNAs are significantly associated with ALL subtype, with few lesions in MLL-rearranged ALL (17, 55) but 6–8 lesions per case in BCR-ABL1 and ETV6-RUNX1 ALL (33, 34).”
InfluentialSelf-citationCBP/p300 in cell growth, transformation, and development
Goodman, R. H., & Smolik, S. (2000) · Genes & Development · doi:10.1101/gad.14.13.1553 · Cited by 1,778
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
Armstrong, S. A., Staunton, J. E., Silverman, L. B., Pieters, R., den Boer, M. L., Minden, M. D., Sallan, S. E., Lander, E. S., Golub, T. R., & Korsmeyer, S. J. (2002) · Nature Genetics · doi:10.1038/ng765 · Cited by 1,723
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596
Self-citationPui, C.-H., Robison, L. L., & Look, A. T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60457-2 · Cited by 1,564
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808253 · Cited by 1,422 · cited 2×
“Despite their high frequency of occurrence, PAX5 alterations are not associated with outcome in ALL (81, 95).”
Self-citationTreating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Pui, C.-H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900386 · Cited by 1,215 · cited 1×
“Data are derived from front-line studies of childhood ALL (121).”
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100 · cited 1×
“MYC rearrangement [t(8;14)(q24;q32), 2 Favorable prognosis with short-term, high-dose chemotherapy 70 t(2;8)(q12;q24)]”
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C. G., Miller, C. B., Radtke, I., Phillips, L. A., Dalton, J., Ma, J., White, D., Hughes, T. P., Le Beau, M. M., Pui, C.-H., et al. (2008) · Nature · doi:10.1038/nature06866 · Cited by 1,072
Self-citationMLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters
Milne, T. A., Briggs, S. D., Brock, H. W., Martin, M. E., Gibbs, D., Allis, C. D., & Hess, J. L. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00741-4 · Cited by 1,053
The ikaros gene is required for the development of all lymphoid lineages
Georgopoulos, K., Bigby, M., Wang, J.-H., Molnar, A., Wu, P., Winandy, S., & Sharpe, A. (1994) · Cell · doi:10.1016/0092-8674(94)90407-3 · Cited by 985
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Pasqualucci, L., Dominguez-Sola, D., Chiarenza, A., Fabbri, G., Grunn, A., Trifonov, V., Kasper, L. H., Lerach, S., Tang, H., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09730 · Cited by 949 · cited 1×
“org Volume 122 Number 10 October 2012 3413 in hyperdiploid ALL (114) and are common at diagnosis in B cell lymphoma samples (115).”
Self-citationDen Boer, M. L., van Slegtenhorst, M., De Menezes, R. X., Cheok, M. H., Buijs-Gladdines, J. G., Peters, S. T., Van Zutven, L. J., Beverloo, H. B., Van der Spek, P. J., Escherich, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70339-5 · Cited by 930
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Majer, C. R., Sneeringer, C. J., Song, J., Johnston, L. D., Scott, M. P., Smith, J. J., Xiao, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.009 · Cited by 923 · cited 3×
“The nature and frequency of these CNAs are significantly associated with ALL subtype, with few lesions in MLL-rearranged ALL (17, 55) but 6–8 lesions per case in BCR-ABL1 and ETV6-RUNX1 ALL (33, 34).”
Genetic variegation of clonal architecture and propagating cells in leukaemia
Anderson, K., Lutz, C., van Delft, F. W., Bateman, C. M., Guo, Y., Colman, S. M., Kempski, H., Moorman, A. V., Titley, I., Swansbury, J., et al. (2011) · Nature · doi:10.1038/nature09650 · Cited by 806
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Mullighan, C. G., Phillips, L. A., Su, X., Ma, J., Miller, C. B., Shurtleff, S. A., & Downing, J. R. (2008) · Science · doi:10.1126/science.1164266 · Cited by 806 · cited 1×
“Microarray profiling has shown that relapse samples exhibit striking differences in the patterns of genomic alterations from the matched diagnosis samples (104–108), with the majority of relapse samples exhibiting the loss of CNAs present at diagnosis and the acquisition of new genetic alterations.”
Self-citationMoorman, A. V., Harrison, C. J., Buck, G. A. N., Richards, S. M., Secker-Walker, L. M., Martineau, M., Vance, G. H., Cherry, A. M., Higgins, R. R., Fielding, A. K., et al. (2007) · Blood · doi:10.1182/blood-2006-10-051912 · Cited by 753
Melo, J. (1996) · Blood · doi:10.1182/blood.v88.7.2375.bloodjournal8872375 · Cited by 723 · cited 2×
“The breakpoints on chromosome 9 are scattered over a nearly 200-kb region within the first intron of ABL , whereas the BCR breakpoints on chromosome 22 are clustered in two areas: a 5.8-kb major BCR (M-bcr) in CML and a minor BCR (m-bcr) in most cases of childhood Ph-positive ALL (30).”
InfluentialRoberts, K. G., Morin, R. D., Zhang, J., Hirst, M., Zhao, Y., Su, X., Chen, S.-C., Payne-Turner, D., Churchman, M. L., Harvey, R. C., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.005 · Cited by 714
Self-citationSchultz, K. R., Bowman, W. P., Aledo, A., Slayton, W. B., Sather, H., Devidas, M., Wang, C., Davies, S. M., Gaynon, P. S., Trigg, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2514 · Cited by 701 · cited 1×
“The addition of imatinib to intensive chemotherapy in childhood BCR-ABL1–positive ALL results in a 4-year event-free survival rate of 84%, more than double that of historical controls (42).”
Prenatal origin of acute lymphoblastic leukaemia in children
Wiemels, J., Cazzaniga, G., Daniotti, M., Eden, O., Addison, G., Masera, G., Saha, V, Biondi, A., & Greaves, M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)09403-9 · Cited by 654
CREBBP mutations in relapsed acute lymphoblastic leukaemia
Mullighan, C. G., Zhang, J., Kasper, L. H., Lerach, S., Payne-Turner, D., Phillips, L. A., Heatley, S. L., Holmfeldt, L., Collins-Underwood, J. R., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09727 · Cited by 637
Self-citationRearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia
Mullighan, C. G., Collins-Underwood, J. R., Phillips, L. A. A., Loudin, M. G., Liu, W., Zhang, J., Ma, J., Coustan-Smith, E., Harvey, R. C., Willman, C. L., et al. (2009) · Nature Genetics · doi:10.1038/ng.469 · Cited by 623 · cited 2×
“3 and is rearranged or mutated in up to 7% of B-ALL cases (71, 72).”
Self-citationZiemin-van der Poel, S., McCabe, N. R., Gill, H. J., Espinosa, R., Patel, Y., Harden, A., Rubinelli, P., Smith, S. D., LeBeau, M. M., & Rowley, J. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10735 · Cited by 585
Harvey, R. C., Mullighan, C. G., Chen, I.-M., Wharton, W., Mikhail, F. M., Carroll, A. J., Kang, H., Liu, W., Dobbin, K. K., Smith, M. A., et al. (2010) · Blood · doi:10.1182/blood-2009-09-245944 · Cited by 574 · cited 2×
“In non-DS ALL, CRLF2 rearrangements are associated with IKZF1 alteration, JAK mutation, and poor outcome (74, 78).”
Self-citationJAK mutations in high-risk childhood acute lymphoblastic leukemia
Mullighan, C. G., Zhang, J., Harvey, R. C., Collins-Underwood, J. R., Schulman, B. A., Phillips, L. A., Tasian, S. K., Loh, M. L., Su, X., Liu, W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811761106 · Cited by 562 · cited 1×
“Val617Phe mutation, the JAK1/2 mutant alleles observed in ALL confer cytokine-independent proliferation in cultured cells, particularly in the presence of a cytokine receptor such as the EPOR or CRLF2, suggesting that a receptor scaffold is required for mutant JAK alleles to drive proliferation and lymphoid transforma…”
Self-citationH3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
Krivtsov, A. V., Feng, Z., Lemieux, M. E., Faber, J., Vempati, S., Sinha, A. U., Xia, X., Jesneck, J., Bracken, A. P., Silverman, L. B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.001 · Cited by 550 · cited 2×
“H3K79 methylation is a mark of actively transcribed genes, and suppression or inactivation of DOT1L in human or murine leukemia cells leads to suppression of the MLL fusion protein– induced gene expression program (63), differentiation and/or apoptosis of leukemic cell lines, and suppression of leukemogenesis (65).”
Shurtleff, S. A., Buijs, A., Behm, F. G., Rubnitz, J. E., Raimondi, S. C., Hancock, M. L., Chan, G., Pui, C., Grosveld, G. C., & Downing, J. R. (1995) · PubMed · Cited by 547
The helix-loop-helix gene E2A is required for B cell formation
ZHUANG, Y. (1994) · Cell · doi:10.1016/0092-8674(94)90076-0 · Cited by 545 · cited 3×
“The t(9;22) fuses 5′ sequences of breakpoint cluster region (BCR) to 3′ sequences from ABL1, which encodes a tyrosine kinase.”
Germline genomic variants associated with childhood acute lymphoblastic leukemia
Treviño, L. R., Yang, W., French, D., Hunger, S. P., Carroll, W. L., Devidas, M., Willman, C., Neale, G., Downing, J., Raimondi, S. C., et al. (2009) · Nature Genetics · doi:10.1038/ng.432 · Cited by 502
Russell, L. J., Capasso, M., Vater, I., Akasaka, T., Bernard, O. A., Calasanz, M. J., Chandrasekaran, T., Chapiro, E., Gesk, S., Griffiths, M., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208397 · Cited by 498
Papaemmanuil, E., Hosking, F. J., Vijayakrishnan, J., Price, A., Olver, B., Sheridan, E., Kinsey, S. E., Lightfoot, T., Roman, E., Irving, J. A. E., et al. (2009) · Nature Genetics · doi:10.1038/ng.430 · Cited by 482 · cited 2×
“Although the functional effects of these inherited variants are poorly understood, the IKZF1 variants may influence level of IKZF1 gene expression (119), suggesting a direct role for these variants in disease susceptibility.”
Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells
Notta, F., Mullighan, C. G., Wang, J. C. Y., Poeppl, A., Doulatov, S., Phillips, L. A., Ma, J., Minden, M. D., Downing, J. R., & Dick, J. E. (2011) · Nature · doi:10.1038/nature09733 · Cited by 463
Self-citationSecondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid Leukemia
Pui, C.-H., Behm, F. G., Raimondi, S. C., Dodge, R. K., George, S. L., Rivera, G. K., Mirro, J., Kalwinsky, D. K., Dahl, G. V., Murphy, S. B., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210302 · Cited by 441
The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins.
Molnár, A., & Georgopoulos, K. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8292 · Cited by 434
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia
Zenatti, P. P., Ribeiro, D., Li, W., Zuurbier, L., Silva, M. C., Paganin, M., Tritapoe, J., Hixon, J. A., Silveira, A. B., Cardoso, B. A., et al. (2011) · Nature Genetics · doi:10.1038/ng.924 · Cited by 416 · cited 1×
“Recently, activating mutations in IL-7R have been identified in both B-ALL and T-lineage ALL, including cases of CRLF2 rearrangement (10, 79, 80).”
Bain, G., Engel, I., Robanus Maandag, E. C., te Riele, H. P. J., Voland, J. R., Sharp, L. L., Chun, J., Huey, B., Pinkel, D., & Murre, C. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4782 · Cited by 400 · cited 1×
“TCF3 encodes the basic helix-loop-helix (bHLH) transcription factors E12 and E47 that are required for early lymphoid development, and loss of E12/E47 promotes the development of T cell lymphoma (22, 23).”
Armstrong, S. A., Kung, A. L., Mabon, M. E., Silverman, L. B., Stam, R. W., Den Boer, M. L., Pieters, R., Kersey, J. H., Sallan, S. E., Fletcher, J. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00003-5 · Cited by 398
Kuiper, R. P., Schoenmakers, E. F. P. M., van Reijmersdal, S. V., Hehir-Kwa, J. Y., van Kessel, A. G., van Leeuwen, F. N., & Hoogerbrugge, P. M. (2007) · Leukemia · doi:10.1038/sj.leu.2404691 · Cited by 365
Shochat, C., Tal, N., Bandapalli, O. R., Palmi, C., Ganmore, I., te Kronnie, G., Cario, G., Cazzaniga, G., Kulozik, A. E., Stanulla, M., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110580 · Cited by 351
Hertzberg, L., Vendramini, E., Ganmore, I., Cazzaniga, G., Schmitz, M., Chalker, J., Shiloh, R., Iacobucci, I., Shochat, C., Zeligson, S., et al. (2010) · Blood · doi:10.1182/blood-2009-08-235408 · Cited by 346
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia
Yoda, A., Yoda, Y., Chiaretti, S., Bar-Natan, M., Mani, K., Rodig, S. J., West, N., Xiao, Y., Brown, J. R., Mitsiades, C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911726107 · Cited by 340 · cited 1×
“Phe232Cys mutation in the transmembrane domain of CRLF2 results in receptor dimerization and overexpression (73).”
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
Bercovich, D., Ganmore, I., Scott, L. M., Wainreb, G., Birger, Y., Elimelech, A., Shochat, C., Cazzaniga, G., Biondi, A., Basso, G., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61341-0 · Cited by 337 · cited 1×
“Val617Phe mutation, the JAK1/2 mutant alleles observed in ALL confer cytokine-independent proliferation in cultured cells, particularly in the presence of a cytokine receptor such as the EPOR or CRLF2, suggesting that a receptor scaffold is required for mutant JAK alleles to drive proliferation and lymphoid transforma…”
HOXA9 is required for survival in human MLL-rearranged acute leukemias
Faber, J., Krivtsov, A. V., Stubbs, M. C., Wright, R., Davis, T. N., van den Heuvel-Eibrink, M., Zwaan, C. M., Kung, A. L., & Armstrong, S. A. (2009) · Blood · doi:10.1182/blood-2007-09-113597 · Cited by 333 · cited 1×
“Co-expression of HOXA genes and MEIS1 cooperates with MLL fusions in induction of leukemia and maintenance of a “stem cell–like” state of maturation (58).”
Chen, C., Sorensen, P., Domer, P., Reaman, G., Korsmeyer, S., Heerema, N., Hammond, G., & Kersey, J. (1993) · Blood · doi:10.1182/blood.v81.9.2386.2386 · Cited by 318 · cited 1×
“MLL–rearranged B-ALL Mixed-lineage leukemia–rearranged (MLL-rearranged) leukemia is a unique entity notable for initiation in utero, for myeloid and lymphoid features, and for poor responsiveness to therapy (44, 45).”
Martinelli, G., Iacobucci, I., Storlazzi, C. T., Vignetti, M., Paoloni, F., Cilloni, D., Soverini, S., Vitale, A., Chiaretti, S., Cimino, G., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6408 · Cited by 317
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Mullighan, C. G., Phillips, L. A., Su, X., Ma, J., Miller, C. B., & Downing, J. R. (2008) · Blood · doi:10.1182/blood.v112.11.429.429 · Cited by 309
Self-citationOutcome of treatment in children with hypodiploid acute lymphoblastic leukemia
Nachman, J. B., Heerema, N. A., Sather, H., Camitta, B., Forestier, E., Harrison, C. J., Dastugue, N., Schrappe, M., Pui, C.-H., Basso, G., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038299 · Cited by 304 · cited 4×
“Conversely, hypodiploidy, with fewer than 44 chromosomes, is associated with dismal prognosis (4).”
InfluentialFusion of the Leucine Zipper Gene HLF to the E2A Gene in Human Acute B-Lineage Leukemia
Inaba, T., Roberts, W. M., Shapiro, L. H., Jolly, K. W., Raimondi, S. C., Smith, S. D., & Look, A. T. (1992) · Science · doi:10.1126/science.1386162 · Cited by 287 · cited 1×
“a member of the PAR family of basic leucine zipper transcription factors (26).”
Zhang, J., Mullighan, C. G., Harvey, R. C., Wu, G., Chen, X., Edmonson, M., Buetow, K. H., Carroll, W. L., Chen, I.-M., Devidas, M., et al. (2011) · Blood · doi:10.1182/blood-2011-03-341412 · Cited by 277
Self-citationThe t(12;21) Translocation Converts AML-1B from an Activator to a Repressor of Transcription
Hiebert, S. W., Sun, W., Nathan Davis, J., Golub, T., Shurtleff, S., Buijs, A., Downing, J. R., Grosveld, G., Roussel, M. F., Gary Gilliland, D., et al. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1349 · Cited by 272
The MLL recombinome of acute leukemias
Meyer, C., Schneider, B., Jakob, S., Strehl, S., Attarbaschi, A., Schnittger, S., Schoch, C., Jansen, M. W. J. C., van Dongen, J. J. M., den Boer, M. L., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404150 · Cited by 271 · cited 1×
“Over 80 partners of MLL rearrangement have been identified (50).”
IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL
Kuiper, R. P., Waanders, E., van der Velden, V. H. J., van Reijmersdal, S. V., Venkatachalam, R., Scheijen, B., Sonneveld, E., van Dongen, J. J. M., Veerman, A. J. P., van Leeuwen, F. N., et al. (2010) · Leukemia · doi:10.1038/leu.2010.87 · Cited by 268 · cited 1×
“IKZF1 alterations are present in up to one-third of highrisk B-ALL cases and triple the risk of treatment failure (81, 96).”
Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL
Wang, L. C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.14.4374 · Cited by 267
Aricò, M., Schrappe, M., Hunger, S. P., Carroll, W. L., Conter, V., Galimberti, S., Manabe, A., Saha, V., Baruchel, A., Vettenranta, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1325 · Cited by 240 · cited 1×
“Historically, BCR-ABL1 ALL has been associated with extremely poor outcome (29, 39).”
Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia
Harrison, C. J., Moorman, A. V., Broadfield, Z. J., Cheung, K. L., Harris, R. L., Reza Jalali, G., Robinson, H. M., Barber, K. E., Richards, S. M., Mitchell, C. D., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04948.x · Cited by 236 · cited 1×
“Hypodiploid ALL Hypodiploidy, with fewer than 44 chromosomes, is present in up to 3% of childhood ALL cases and is associated with a high risk of treatment failure (89).”
Crist, W., Carroll, A., Shuster, J., Jackson, J., Head, D., Borowitz, M., Behm, F., Link, M., Steuber, P., & Ragab, A. (1990) · Blood · doi:10.1182/blood.v76.3.489.489 · Cited by 225 · cited 1×
“older age, higher leukocyte count, and more frequent CNS leukemia at diagnosis (38).”
Cario, G., Zimmermann, M., Romey, R., Gesk, S., Vater, I., Harbott, J., Schrauder, A., Moericke, A., Izraeli, S., Akasaka, T., et al. (2010) · Blood · doi:10.1182/blood-2009-11-256131 · Cited by 225
Iacobucci, I., Storlazzi, C. T., Cilloni, D., Lonetti, A., Ottaviani, E., Soverini, S., Astolfi, A., Chiaretti, S., Vitale, A., Messa, F., et al. (2009) · Blood · doi:10.1182/blood-2008-08-173963 · Cited by 222 · cited 4×
“The nature and frequency of these CNAs are significantly associated with ALL subtype, with few lesions in MLL-rearranged ALL (17, 55) but 6–8 lesions per case in BCR-ABL1 and ETV6-RUNX1 ALL (33, 34).”
InfluentialCytogenetics of paediatric and adolescent acute lymphoblastic leukaemia
Harrison, C. J. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07417.x · Cited by 216 · cited 3×
“Approximately 75% of B-ALL cases exhibit aneuploidy or a recurring gross chromosomal rearrangement (1, 2) (Table 1 and Figure 1).”
Biology and treatment of infant leukemias.
Pui, C., Kane, J. R., & Crist, W. (1995) · PubMed · Cited by 213
Hunger, S. (1996) · Blood · doi:10.1182/blood.v87.4.1211.bloodjournal8741211 · Cited by 213 · cited 5×
“t(12;21)(p13;q22) ETV6-RUNX1 15–25 Expression of myeloid antigens; excellent outcome 5”
InfluentialHof, J., Krentz, S., van Schewick, C., Körner, G., Shalapour, S., Rhein, P., Karawajew, L., Ludwig, W.-D., Seeger, K., Henze, G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.8144 · Cited by 208
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition
Duy, C., Hurtz, C., Shojaee, S., Cerchietti, L., Geng, H., Swaminathan, S., Klemm, L., Kweon, S.-M., Nahar, R., Braig, M., et al. (2011) · Nature · doi:10.1038/nature09883 · Cited by 204 · cited 1×
“inhibitors results in the activation of the transcription factor BCL6, which may directly influence responsiveness to treatment with these agents (32).”
ETV6: A versatile player in leukemogenesis
Bohlander, S. K. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.01.008 · Cited by 204 · cited 1×
“ETV6 is a member of the ETS family of transcription factors that are frequently targeted by rearrangements and mutations in leukemia and other malignancies (6).”
Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia
Nebral, K., Denk, D., Attarbaschi, A., König, M., Mann, G., Haas, O. A., & Strehl, S. (2009) · Leukemia · doi:10.1038/leu.2008.306 · Cited by 204 · cited 1×
“sequence mutations that disrupt DNA binding or truncate the transactivating domain (17, 93), and translocations that create chimeric fusion proteins (17, 93, 94).”
11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
Pui, C. H., Behm, F. G., Downing, J. R., Hancock, M. L., Shurtleff, S. A., Ribeiro, R. C., Head, D. R., Mahmoud, H. H., Sandlund, J. T., & Furman, W. L. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.909 · Cited by 201 · cited 1×
“MLL–rearranged B-ALL Mixed-lineage leukemia–rearranged (MLL-rearranged) leukemia is a unique entity notable for initiation in utero, for myeloid and lymphoid features, and for poor responsiveness to therapy (44, 45).”
Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation
Jo, S. Y., Granowicz, E. M., Maillard, I., Thomas, D., & Hess, J. L. (2011) · Blood · doi:10.1182/blood-2010-12-327668 · Cited by 199
Kawamata, N., Ogawa, S., Zimmermann, M., Kato, M., Sanada, M., Hemminki, K., Yamatomo, G., Nannya, Y., Koehler, R., Flohr, T., et al. (2008) · Blood · doi:10.1182/blood-2007-05-088310 · Cited by 199
Results of Therapy for Acute Lymphoblastic Leukemia in Black and White Children
Pui, C.-H. (2003) · JAMA · doi:10.1001/jama.290.15.2001 · Cited by 199
Yang, J. J., Bhojwani, D., Yang, W., Cai, X., Stocco, G., Crews, K., Wang, J., Morrison, D., Devidas, M., Hunger, S. P., et al. (2008) · Blood · doi:10.1182/blood-2008-06-165027 · Cited by 194
Advances in the understanding of MYC‐induced lymphomagenesis
Klapproth, K., & Wirth, T. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08159.x · Cited by 181
Yan, L., Ping, N., Zhu, M., Sun, A., Xue, Y., Ruan, C., Drexler, H. G., MacLeod, R. A. F., Wu, D., & Chen, S. (2012) · Haematologica · doi:10.3324/haematol.2012.064485 · Cited by 173
Ribeiro, R., Abromowitch, M., Raimondi, S., Murphy, S., Behm, F., & Williams, D. (1987) · Blood · doi:10.1182/blood.v70.4.948.948 · Cited by 173
Inukai, T., Kiyokawa, N., Campana, D., Coustan‐Smith, E., Kikuchi, A., Kobayashi, M., Takahashi, H., Koh, K., Manabe, A., Kumagai, M., et al. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08955.x · Cited by 163 · cited 1×
“occurs in older children or adolescents and has been reported to be associated with poor outcome (87), although this association may not be independent of other established prognostic variables such”
Heltemes-Harris, L. M., Willette, M. J. L., Ramsey, L. B., Qiu, Y. H., Neeley, E. S., Zhang, N., Thomas, D. A., Koeuth, T., Baechler, E. C., Kornblau, S. M., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101947 · Cited by 161 · cited 1×
“TCF3-HLF–positive leukemia is associated with older age and very poor outcome (28).”
New mechanisms of AML1 gene alteration in hematological malignancies
Roumier, C., Fenaux, P., Lafage‐Pochitaloff, M., Imbert, M., Éclache, V., & Preudhomme, C. (2003) · Leukemia · doi:10.1038/sj.leu.2402766 · Cited by 159
Harewood, L., Robinson, H. M., Harris, R., Al-Obaidi, M. J., Jalali, G. R., Martineau, M., Moorman, A. V., Sumption, N. D., Richards, S. M., Mitchell, C., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402849 · Cited by 158 · cited 1×
“Intrachromosomal amplification of chromosome 21 Intrachromosomal amplification of chromosome 21 (iAMP21) occurs in up to 2% of B-progenitor ALL cases (85).”
Stumpel, D. J. P. M., Schneider, P., van Roon, E. H. J., Boer, J. M., de Lorenzo, P., Valsecchi, M. G., de Menezes, R. X., Pieters, R., & Stam, R. W. (2009) · Blood · doi:10.1182/blood-2009-06-227660 · Cited by 157
Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1
Jeha, S., Pei, D., Raimondi, S. C., Onciu, M. M., Campana, D., Chen, C., Sandlund, J. T., Ribeiro, R. C., Rubnitz, J. E., Howard, S. C., et al. (2009) · Leukemia · doi:10.1038/leu.2009.42 · Cited by 154
Milani, L., Lundmark, A., Kiialainen, A., Nordlund, J., Flaegstad, T., Forestier, E., Heyman, M., Jonmundsson, G., Kanerva, J., Schmiegelow, K., et al. (2010) · Blood · doi:10.1182/blood-2009-04-214668 · Cited by 146 · cited 1×
“Several studies profiling cytosine methylation have shown that different ALL subgroups exhibit distinct methylation profiles and that promoter methylation is associated with gene expression and outcome (67, 68).”
Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X
Chessells, J. M., Swansbury, G. J., Reeves, B. R., Bailey, C. C., & Richards, S. M. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.3493163.x · Cited by 146 · cited 1×
“Rearrangement of the MLL gene at 11q23 occurs in at least two-thirds of infants with ALL, 5% of AML, and 85% of secondary leukemias that occur in patients treated with topoisomerase II inhibitors (46, 47) but is less frequent in older individuals (48, 49).”
Andreasson, P., Schwaller, J., Anastasiadou, E., Aster, J. C., & Gilliland, D. G. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00518-0 · Cited by 137
Cytogenetics and molecular genetics of acute lymphoblastic leukemia
Harrison, C. J., & Foroni, L. (2002) · Reviews in Clinical and Experimental Hematology · doi:10.1046/j.1468-0734.2002.00069.x · Cited by 128 · cited 1×
“Hyperdiploidy, with gain of at least 5 chromosomes, is one of the most frequent alterations in childhood ALL and is associated with favorable outcome (3).”
Stubbs, M. C., Kim, Y., Krivtsov, A. V., Wright, R. D., Feng, Z., Agarwal, J., Kung, A. L., & Armstrong, S. A. (2007) · Leukemia · doi:10.1038/sj.leu.2404951 · Cited by 124
Kuster, L., Grausenburger, R., Fuka, G., Kaindl, U., Krapf, G., Inthal, A., Mann, G., Kauer, M. O., Rainer, J., Kofler, R., et al. (2011) · Blood · doi:10.1182/blood-2010-03-275347 · Cited by 122 · cited 1×
“Microarray profiling has shown that relapse samples exhibit striking differences in the patterns of genomic alterations from the matched diagnosis samples (104–108), with the majority of relapse samples exhibiting the loss of CNAs present at diagnosis and the acquisition of new genetic alterations.”
Schafer, E. S., Irizarry, R. A., Negi, S., McIntyre, E., Small, D., Figueroa, M. E., Melnick, A. M., & Brown, P. A. (2010) · Blood · doi:10.1182/blood-2009-09-243634 · Cited by 122 · cited 1×
“Several studies profiling cytosine methylation have shown that different ALL subgroups exhibit distinct methylation profiles and that promoter methylation is associated with gene expression and outcome (67, 68).”
Morrow, M., Horton, S. J., Kioussis, D., Brady, H. J. M., & Williams, O. (2004) · Blood · doi:10.1182/blood-2003-10-3695 · Cited by 116 · cited 1×
“Expression of ETV6-RUNX1 promotes self-renewal in B cell progenitors but alone does not induce leukemia (14, 15).”
Lahoud, M. H., Ristevski, S., Venter, D. J., Jermiin, L. S., Bertoncello, I., Zavarsek, S., Hasthorpe, S., Drago, J., de Kretser, D., Hertzog, P. J., et al. (2001) · Genome Research · doi:10.1101/gr.168801 · Cited by 115
Chessells, J. M., Harrison, C. J., Kempski, H. M., Webb, D. K. H., Wheatley, K., Hann, I. M., Stevens, R., Harrison, G., & Gibson, B. E. S. (2002) · Leukemia · doi:10.1038/sj.leu.2402468 · Cited by 113
Paulsson, K., Horvat, A., Strömbeck, B., Nilsson, F., Heldrup, J., Behrendtz, M., Forestier, E., Andersson, A., Fioretos, T., & Johansson, B. (2008) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20502 · Cited by 111 · cited 1×
“Candidate gene sequencing approaches have identified additional sequence mutations in B-ALL, most commonly mutations resulting in activation in RAS signaling, which are enriched in MLL and hyperdiploid ALL (98, 99).”
Stumpel, D. J. P. M., Schotte, D., Turenhout, E. A. M., Schneider, P., Seslija, L., de Menezes, R. X., Márquez, V. E., Pieters, R., den Boer, M. L., & Stam, R. W. (2010) · Leukemia · doi:10.1038/leu.2010.282 · Cited by 111
Attarbaschi, A., Mann, G., Panzer‐Grümayer, R., Röttgers, S., Steiner, M., König, M., Csinady, E., Dworzak, M. N., Seidel, M. G., Janousek, D., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.1117 · Cited by 111
Bateman, C. M., Colman, S. M., Chaplin, T., Young, B. D., Eden, T. O., Bhakta, M., Gratias, E. J., van Wering, E. R., Cazzaniga, G., Harrison, C. J., et al. (2010) · Blood · doi:10.1182/blood-2009-10-251413 · Cited by 108
Inthal, A., Zeitlhofer, P., Zeginigg, M., Morak, M., Grausenburger, R., Fronkova, E., Fahrner, B., Mann, G., Haas, O. A., & Panzer-Grümayer, R. (2012) · Leukemia · doi:10.1038/leu.2012.60 · Cited by 106
Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia
van Delft, F. W., Horsley, S. W., Colman, S., Anderson, K., Bateman, C. M., Kempski, H. M., Zuna, J., Eckert, C., Saha, V., Kearney, L., et al. (2011) · Blood · doi:10.1182/blood-2010-10-314674 · Cited by 101
Virely, C., Moulin, S., Cobaleda, C., Lasgi, C., Alberdi, A., Soulier, J., Sigaux, F., Chan, S. H., Kastner, P., & Ghysdael, J. (2010) · Leukemia · doi:10.1038/leu.2010.63 · Cited by 100 · cited 4×
“Historically, BCR-ABL1 ALL has been associated with extremely poor outcome (29, 39).”
InfluentialBousquet, M., Broccardo, C., Quelen, C., Meggetto, F., Kuhlein, E., Delsol, G., Dastugue, N., & Brousset, P. (2007) · Blood · doi:10.1182/blood-2006-05-025221 · Cited by 100 · cited 1×
“sequence mutations that disrupt DNA binding or truncate the transactivating domain (17, 93), and translocations that create chimeric fusion proteins (17, 93, 94).”
Koppen, I. J. N., Hermans, F. J. R., & Kaspers, G. J. L. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07898.x · Cited by 83
Irving, J. A. E., Minto, L., Bailey, S., & Hall, A. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1227 · Cited by 80
Maloney, K. W., McGavran, L., Odom, L. F., & Hunger, S. P. (1999) · Blood · doi:10.1182/blood.v93.7.2380 · Cited by 79
Robinson, H. M., Harrison, C. J., Moorman, A. V., Chudoba, I., & Strefford, J. C. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20412 · Cited by 75 · cited 1×
“iAMP21 is characterized by commonly complex patterns of chromosomal rearrangement suggestive of a breakage-fusion-bridge cycle (86).”
Dyer, M. J. S., Akasaka, T., Capasso, M., Dusanjh, P., Lee, Y. F., Karran, E. L., Nagel, I., Vater, I., Cario, G., & Siebert, R. (2009) · Blood · doi:10.1182/blood-2009-09-235986 · Cited by 73
B-cell development fails in the absence of the Pbx1 proto-oncogene
Sanyal, M., Tung, J. W., Karsunky, H., Zeng, H., Selleri, L., Weissman, I. L., Herzenberg, L. A., & Cleary, M. L. (2007) · Blood · doi:10.1182/blood-2006-10-054213 · Cited by 72
PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia
Yamamoto, T., Isomura, M., Xu, Y., Liang, J. B., Yagasaki, H., Kamachi, Y., Kudo, K., Kiyoi, H., Naoe, T., & Kojma, S. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.02.004 · Cited by 70 · cited 1×
“Candidate gene sequencing approaches have identified additional sequence mutations in B-ALL, most commonly mutations resulting in activation in RAS signaling, which are enriched in MLL and hyperdiploid ALL (98, 99).”
Pfeifer, R., Lange, T., Wystub, S., Waßmann, B., Maier, J., Binckebanck, A., Giagounidis, A. A. N., Stelljes, M., Schmalzing, M., Dührsen, U., et al. (2012) · Leukemia · doi:10.1038/leu.2012.5 · Cited by 68
Szczepański, T., van der Velden, V. H. J., Waanders, E., Kuiper, R. P., Vlierberghe, P. V., Gruhn, B., Eckert, C., Panzer‐Grümayer, R., Basso, G., Cavé, H., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2877 · Cited by 67
Lü, Q., & Kamps, M. P. (1997) · Oncogene · doi:10.1038/sj.onc.1200799 · Cited by 67 · cited 1×
“TCF3-PBX1 binds HOX proteins and likely interferes with hematopoietic differentiation by disrupting HOX-regulated gene expression (25).”
Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia
Nebral, K., Denk, D., Attarbaschi, A., König, M., Mann, G., Haas, O., & Strehl, S. (2009) · Klinische Pädiatrie · doi:10.1055/s-0029-1222663 · Cited by 65
Torrano, V., Procter, J., Cardus, P., Greaves, M. F., & Ford, A. M. (2011) · Blood · doi:10.1182/blood-2011-05-354266 · Cited by 62
Parker, H., An, Q., Barber, K., Case, M., Davies, T., Konn, Z., Stewart, A., Wright, S., Griffiths, M., Ross, F. M., et al. (2008) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20613 · Cited by 60
Iacobucci, I., Lonetti, A., Paoloni, F. P., Papayannidis, C., Ferrari, A., Storlazzi, C. T., Vignetti, M., Cilloni, D., Messa, F., Guadagnuolo, V., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.020792 · Cited by 60
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4
Bardini, M., Spinelli, R., Bungaro, S., Mangano, E., Corral, L., Cifola, I., Fazio, G., Giordan, M., Basso, G., Rossi, G., et al. (2009) · Leukemia · doi:10.1038/leu.2009.203 · Cited by 59 · cited 2×
“The nature and frequency of these CNAs are significantly associated with ALL subtype, with few lesions in MLL-rearranged ALL (17, 55) but 6–8 lesions per case in BCR-ABL1 and ETV6-RUNX1 ALL (33, 34).”
Studying the pathogenesis of BCR–ABL+ leukemia in mice
Etten, R. A. V. (2002) · Oncogene · doi:10.1038/sj.onc.1206091 · Cited by 56
Cytogenetically different leukemic clones at relapse of childhood acute lymphoblastic leukemia
Raimondi, S., Pui, C., Head, D., Rivera, G. K., & Behm, F. (1993) · Blood · doi:10.1182/blood.v82.2.576.576 · Cited by 51
de Boer, J., Yeung, J., Ellu, J., Ramanujachar, R., Bornhauser, B. C., Solarska, O., Hubank, M. J. F., Williams, O., & Brady, H. J. M. (2010) · Leukemia · doi:10.1038/leu.2010.253 · Cited by 43 · cited 1×
“TCF3-HLF aberrantly regulates genes that control cell death in lymphoid progenitors, including LMO2 and BCL2 (27).”
Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia
Kawamata (2009) · International Journal of Oncology · doi:10.3892/ijo_00000290 · Cited by 38
ERG Deletions Define a Novel Subtype of B-Progenitor Acute Lymphoblastic Leukemia.
Mullighan, C. G., Miller, C. B., Su, X., Radtke, I., Dalton, J., Song, G., Zhou, X., Pui, C., Shurtleff, S. A., & Downing, J. R. (2007) · Blood · doi:10.1182/blood.v110.11.691.691 · Cited by 30
Self-citationMoorman, A. V., Raimondi, S., Pui, C.-H., Baruchel, A., Biondi, A., Carroll, A. J., Forestier, E., Gaynon, P. S., Harbott, J., Harms, D., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403695 · Cited by 24 · cited 1×
“The most common MLL rearrangements are t(4;11)(q21;q23)/ MLL-AFF1(AF4), found in approximately 50% of cases, followed by t(9;11)(p22;q23)/MLL-MLLT3(AF9), MLL-ENL, and t(10;11) (p13-15;q14-21)/MLL-MLLT10(AF10) (51, 52).”
Single Nucleotide Polymorphism Microarray Analysis of Genetic Alterations in Cancer
Mullighan, C. G. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-074-4_17 · Cited by 17 · cited 1×
“The advent of array-comparative genomic hybridization and SNP microarrays has enabled interrogation of structural genetic alterations at very high resolution (91).”
Self-citationLoh, M. L., Harvey, R. C., Mullighan, C. G., Linda, S. B., Devidas, M., Borowitz, M. J., Carroll, A. J., Chen, I., Gastier, J. M., Heerema, N. A., et al. (2011) · Blood · doi:10.1182/blood.v118.21.743.743 · Cited by 10 · cited 1×
“Up to 15% of childhood B-ALL cases exhibit a gene expression profile similar to that of BCR-ABL1–positive ALL, often have deletion/mutation of IZKF1 , and have a very poor outcome (81–83).”
Self-citationHolmfeldt, L., Zhang, J., Ma, J., Devidas, M., Carroll, A. J., Heerema, N. A., Gastier, J. M., Raimondi, S. C., Loh, M. L., Hunger, S. P., et al. (2010) · Blood · doi:10.1182/blood.v116.21.411.411 · Cited by 6 · cited 1×
“NH ALL has a very high frequency of deletions and sequence mutations that activate RAS signaling, and NH and LH ALL have a high frequency of inactivating alterations of IKAROS genes IKZF2 (HELIOS) and IKZF3 (AIOLOS) that are otherwise rare in ALL (90).”
Self-citation
Research works printed but not linked: 2
- Andersson AK, et al. Whole genome sequence anal- ysis of 22 MLL rearranged infant acute lympho- blastic leukemias reveals remarkably few somatic mutations: a report from the St. Jude Children's Research Hospital -Washington University Pedi- atric Cancer Genome Project. ASH Annual Meeting Abstracts. 2011;118:69.
- Mullighan, 2007, 110, 691
Cited by
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
Self-citationGokbuget, N., Dombret, H., Ribera, J.-M., Fielding, A. K., Advani, A., Bassan, R., Chia, V., Doubek, M., Giebel, S., Hoelzer, D., et al. (2016) · Haematologica · doi:10.3324/haematol.2016.144311 · Cited by 227
“50 In 3 salvage Without prior HSCT 12/108 11 (6, 19) 108 2.”
Oshima, K., Khiabanian, H., da Silva-Almeida, A. C., Tzoneva, G., Abate, F., Ambesi-Impiombato, A., Sanchez-Martin, M., Carpenter, Z., Penson, A., Perez-Garcia, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608420113 · Cited by 194
“Recurrently somatically mutated genes in our series included known oncogenes and tumor suppressors mutated in B-cell precursor ALL [KRAS, NRAS, Fms related tyrosine kinase 3 (FLT3), Janus kinase 2 (JAK2), Janus kinase 3 (JAK3), and CREBBP] (20) and T-cell ALL [Notch1 (NOTCH1), FBXW7, PHF6, DNM2, WT1, JAK1, JAK3, BCL11…”
BackgroundGenomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia
Lim, J. Y., Bhatia, S., Robison, L. L., & Yang, J. J. (2014) · Cancer · doi:10.1002/cncr.28531 · Cited by 180
“Recent high-throughput genomic profiling of ALL (eg, genomewide gene expression, DNA copy number, and single nucleotide polymorphism [SNP] genotype) has dramatically improved our understanding of the genetic landscape of this disease and has also led to the discovery of novel molecular markers for treatment individual…”
BackgroundPalanichamy, J. K., Tran, T. M., Howard, J. M., Contreras, J. R., Fernando, T. R., Sterne-Weiler, T., Katzman, S., Toloue, M., Yan, W., Basso, G., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80046 · Cited by 168
“org Volume 126 Number 4 April 2016 Introduction Oncogenesis in early B cell progenitors results in B cell acute lymphoblastic leukemia (B-ALL), the most prevalent hematological neoplasm in children and young adults (1).”
Background
Metadata
- Authors
- Mullighan, C. G.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Mullighan, Charles G.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-01
- Volume
- 122
- Issue
- 10
- Pages
- 3407-3415
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3461902
- OpenAlex
- W2146473098
- Cited by
- 247
- References
- 127
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 12 · 2023: 10 · 2022: 15 · 2021: 17 · 2020: 22 · 2019: 21 · 2018: 15 · 2017: 30 · 2016: 32 · 2015: 16 · 2014: 20 · 2013: 17 · 2012: 1
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- American Society of Hematology
- St. Jude Children's Research Hospital
- American Lebanese Syrian Associated Charities (38105)
- Children’s Oncology Group
- Stand Up To Cancer
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- B-cell precursor acute lymphoblastic leukemia, somatic alterations, chromosomal rearrangements, aneuploidy, prognosis, leukemogenesis, genetic profiling, childhood cancer
- MeSH terms
- Adult, Animals, B-Lymphocytes, Child, Clone Cells, Hematopoietic Stem Cells, Humans, Neoplasm Proteins, Prognosis, Risk, Translocation, Genetic, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Oncogene Proteins, Fusion, Mice, Knockout, Cell Lineage, Genetic Predisposition to Disease, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.